心血管

订阅

MedSci主页 / 所有栏目 / 心血管

ACC：心搏骤停的治疗：牢记五点

2015-07-08 大鹏 译 医学论坛网

心搏骤停
关注

美国心脏病学会介入委员会近期完善了关于昏迷患者复苏过程中急诊侵入性心脏手术治疗框架，并发布了相关声明，下列为原文五项要点：1.应制定简便易行的治疗框架以便鉴别诊断心搏骤停后昏迷患者，此类患者适宜接受急诊冠脉造影;2.在患者转诊至导管室前，应邀请包括心脏介入专家在内的多学科专家组紧急会诊磋商，强烈推荐尽早启动低温治疗;3.介入委员会明确表示并强调，心搏

美国心脏病学会介入委员会近期完善了关于昏迷患者复苏过程中急诊侵入性心脏手术治疗框架，并发布了相关声明，下列为原文五项要点：

1.应制定简便易行的治疗框架以便鉴别诊断心搏骤停后昏迷患者，此类患者适宜接受急诊冠脉造影;

2.在患者转诊至导管室前，应邀请包括心脏介入专家在内的多学科专家组紧急会诊磋商，强烈推荐尽早启动低温治疗;

3.介入委员会明确表示并强调，心搏骤停患者的经皮冠状动脉介入治疗(PCI)预后不宜纳入公共报告中;

4.建立国家平台以随访心搏骤停患者PCI预后，并区分ST段抬高型病变与非ST段抬高型病变患者;

5.尚需开展有关非ST段抬高型心脏骤停患者早期PCI效果的随机对照试验。

原始出处：

Debabrata Mukherjee, MD, F.A.C.C.Cardiac Arrest Treatment Algorithm | Five Points to Remember.ACC.Jun 29, 2015.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=32694, encodeId=559a326941b, content=继续, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Tue Jul 14 07:16:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325063, encodeId=4f0c1325063ed, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486998, encodeId=673d148699832, content=<a href='/topic/show?id=8080510465b' target=_blank style='color:#2F92EE;'>#心搏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51046, encryptionId=8080510465b, topicName=心搏骤停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d578248121, createdName=shenxlcyp, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31791, encodeId=e0db31e9189, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:00:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31557, encodeId=549d3155ea7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:09:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-14 保守主义

    继续

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=32694, encodeId=559a326941b, content=继续, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Tue Jul 14 07:16:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325063, encodeId=4f0c1325063ed, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486998, encodeId=673d148699832, content=<a href='/topic/show?id=8080510465b' target=_blank style='color:#2F92EE;'>#心搏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51046, encryptionId=8080510465b, topicName=心搏骤停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d578248121, createdName=shenxlcyp, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31791, encodeId=e0db31e9189, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:00:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31557, encodeId=549d3155ea7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:09:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-10 12498568m50暂无昵称

    #ACC#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=32694, encodeId=559a326941b, content=继续, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Tue Jul 14 07:16:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325063, encodeId=4f0c1325063ed, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486998, encodeId=673d148699832, content=<a href='/topic/show?id=8080510465b' target=_blank style='color:#2F92EE;'>#心搏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51046, encryptionId=8080510465b, topicName=心搏骤停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d578248121, createdName=shenxlcyp, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31791, encodeId=e0db31e9189, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:00:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31557, encodeId=549d3155ea7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:09:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-10 shenxlcyp

    #心搏骤停#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=32694, encodeId=559a326941b, content=继续, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Tue Jul 14 07:16:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325063, encodeId=4f0c1325063ed, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486998, encodeId=673d148699832, content=<a href='/topic/show?id=8080510465b' target=_blank style='color:#2F92EE;'>#心搏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51046, encryptionId=8080510465b, topicName=心搏骤停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d578248121, createdName=shenxlcyp, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31791, encodeId=e0db31e9189, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:00:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31557, encodeId=549d3155ea7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:09:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-09 飞翔9899

    还行

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=32694, encodeId=559a326941b, content=继续, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Tue Jul 14 07:16:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325063, encodeId=4f0c1325063ed, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486998, encodeId=673d148699832, content=<a href='/topic/show?id=8080510465b' target=_blank style='color:#2F92EE;'>#心搏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51046, encryptionId=8080510465b, topicName=心搏骤停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d578248121, createdName=shenxlcyp, createdTime=Fri Jul 10 00:12:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31791, encodeId=e0db31e9189, content=还行, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:00:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31557, encodeId=549d3155ea7, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:09:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-08 huaxipanxing

    看看

    0

相关资讯

Am J Cardiol：D-二聚体浓度较高的心搏骤停患者预后不佳

　　波兰一项研究表明，入院时D-二聚体浓度较高的心搏骤停患者预后不佳；D-二聚体浓度为全因死亡的独立预测因子。论文于5月20日在线发表于《美国心脏病学杂志》（Am J Cardiol）。 　　此项研究共纳入182例因院外心搏骤停的急诊患者，其中男性122例，平均年龄64.3 ± 15岁。回顾性采集有关于初始心搏停止节律、包括入院时D-二聚体浓度在内的生化指

AHA 2013：心肺复苏时间与心搏骤停患者功能转归独立相关

于AHA 2013科学年会公布的美国一项研究表明，随心肺复苏持续时间延长，患者以良好功能转归存活出院的可能性迅速降低；新型复苏策略应在心搏骤停早期尝试，而非在传统手段完全失败后再实施。论文11月17日在线发表于《循环》（Circulation）。【原文出处】 此项回顾性队列研究共纳入1014例非创伤性院外心搏骤停成人患者。以专业医务人员实施心肺复苏或除颤定义院外心搏骤停。利用改良Ran

BMJ：早期给予肾上腺素或可提高心搏骤停患者生存率

在美国，每年约有20万人在院内发生心脏骤停，患者的生存率为7%-26%。在门诊及住院病房中，初始心律出现不能除颤心律（无脉性电活动和心脏骤停）较可电击性心律（室速或室颤）更常见。 过去几十年来，非可电击性心脏骤停的发生率逐年增加，尽管如此，先前的大部分研究仍关注可电击性心跳骤停患者。除了心肺复苏，缺乏拯救非可电击性心脏骤停患者的有效措施。 肾上腺素是一种强有力的外周血管收缩剂，同时也是一种冠状

AHA 2014：血管加压素治疗心搏骤停和创伤 可行？

AHA科学年会复苏科学座谈会上的辩论显示，目前仍需更多研究以确定在心搏骤停或严重创伤患者复苏中应用血管加压素的利弊。 现有证据不足 多伦多大学Morrison教授表示，未来需要确定肾上腺素在心搏骤停中的最佳剂量和应用时机，哪些患者可从血管加压素中获益，以及快速推注和持续输注的选择。尽管一些研究显示肾上腺素可有有益于心搏骤停患者复苏，但仅有的一项肾上腺素与安慰剂随机对照试验并未得

AHA 2014：创伤和心搏骤停的挽救治疗进展

挽救治疗包括主动脉血流阻断、体外膜式氧合(ECMO)和体外生命支持(ECLS)，并被用于标准治疗失败心跳骤停和创伤患者的复苏。AHA 2014复苏科学座谈会与会专家对何时以及如何应用挽救治疗进行了探讨。 美国布鲁克陆军医学中心Berry博士表示，对出血性休克应用挽救治疗时，穿透伤和钝伤患者的生存率分别为7%和1%，并且生存者中有15%伴有神经功能缺损。同时他认为，血管内球囊主动脉闭塞(R

JAMA：加压素-肾上腺素联用可改善心搏骤停患者出院生存

希腊一项研究表明，在需血管升压药治疗的心搏骤停患者中，心肺复苏（CRP）期间联合应用加压素-肾上腺素以及复苏后休克中应用氢化可的松可改善神经转归良好的出院生存率。论文发表于《美国医学会杂志》[JAMA.2013;310(3):270]。 此项随机双盲安慰剂对照研究共纳入268例依据复苏指南需肾上腺素治疗的心搏骤停患者，并在前5个CRP周期给予加压素联合肾上腺素（VSE组，n = 130）或生理盐